Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
A completed clinical trial update detailing pharmacokinetic, immunological, and biochemical sample collection and analysis in a natalizumab-…
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis [Phase 3]
Open-label extension study evaluating safety, tolerability, and activity of oral fampridine-SR in patients with multiple sclerosis; the tria…
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial [Phase 3]
Open-label extension study assessing safety, tolerability, and activity of oral fampridine-SR in multiple sclerosis patients who previously …
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial [Phase 3]
An open-label extension study evaluated the safety, tolerability, and activity of oral fampridine-SR in multiple sclerosis patients who part…
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment [Phase 4]
Phase 4 trial of rivastigmine for cognitive impairment in multiple sclerosis was terminated; results were posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions [Phase 1]
Phase 1 study evaluating the PET imaging tracer [18F] FEPPA as a marker of inflammation in subjects with Alzheimer's disease, Parkinson's di…
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis [Phase 3]
This document reports the completion of a Phase 3 trial evaluating the efficacy and safety of dronabinol for central neuropathic pain in mul…
-
CLINICAL_TRIALS trial_result · 2012-01-24Clinical Trial Update: American Ginseng Treatment for Multiple Sclerosis Related Fatigue [Phase 2]
Phase 2 clinical trial evaluated American ginseng for fatigue in people with multiple sclerosis; the study completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Longitudinal Pharmacokinetic, Pharmacodynamic, Immunological, and Biochemical
This clinical trial update reports longitudinal pharmacokinetic, pharmacodynamic, immunological, and biochemical analyses conducted in peopl…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.
The document reports that the telephone interview study of patients who participated in Bayer's pivotal Betaseron trial for multiple scleros…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis [Phase 3]
Phase 3 trial update evaluating whether progestin and estradiol around childbirth can prevent postpartum relapses in women with multiple scl…
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Duloxetine for Multiple Sclerosis Pain [Phase 3]
Phase 3 trial results investigating duloxetine for multiple sclerosis-related pain have been completed, with results posted in 2011. The spo…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) [Phase 3]
Phase 3 study assessing safety and effectiveness of Sativex for spasticity in multiple sclerosis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis [Phase 4]
Phase 4 trial evaluating doxycycline in combination with interferon-B-1a for multiple sclerosis has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating atorvastatin (Lipitor) in patients with clinically isolated syndrome at risk for multiple sclerosis has completed…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating mesenchymal stem cells as a treatment for multiple sclerosis, conducted by the University of…
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: T Cell Vaccination in Patients With Progressive Multiple Sclerosis [Phase 1, Phase 2]
Completion of Phase 1/2 trials evaluating a T cell vaccination approach for progressive multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2011-09-19Clinical Trial Update: Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy for Multiple Sclerosis [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating Cytotron rotational field quantum nuclear magnetic resonance therapy…
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating colecalciferol as an add-on therapy to subcutaneously administered interferon-beta-1b for multiple sc…
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 [Phase 2]
A Phase 2 placebo-controlled study of CDP323 in relapsing forms of multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Escitalopram (Lexapro) for Depression MS or ALS [Phase 3]
A Phase 3 trial evaluating escitalopram for depression in patients with multiple sclerosis or ALS has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
Clinical trial update describing a follow-up magnetization transfer imaging study in relapsing-remitting multiple sclerosis patients treated…
-
CLINICAL_TRIALS trial_result · 2011-09-05Clinical Trial Update: Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis [Phase 4]
Phase 4 study evaluating whether Vitamin D supplementation can prevent bone loss in people with multiple sclerosis and osteoporosis. The tri…
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS) [NA]
A clinical trial evaluating alternative exercise therapies for progressive multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Health Behavior Change in Chronic Disease Management [NA]
A clinical trial focusing on health behavior change in chronic disease management for Multiple Sclerosis has completed.